Retail sale of pharmaceutical products
FARMAX HOLDING AS
Revenue 2025
NOK 48,000
Operating profit
NOK 34,000
Equity
NOK 683,000
Incorporated
2023
Share capital
NOK 30,000
Key figures · 2025
Current ratio
89.40
Equity ratio
44.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 71.8% | |
| Net margin (%%) | 520.8% | |
| Return on assets (%%) | 2.3% | |
| Likviditet | ||
| Current ratio | 89.40 | |
| Working capital | 448k | |
| Soliditet | ||
| Equity ratio (%%) | 44.6% | |
| Debt-to-equity ratio | 1.24 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.